Advanced Fellowship in Multiple Myeloma

Advanced Fellowship in Multiple Myeloma

Dana-Farber Cancer Institute

Cancer Center

Boston, MA

The Advanced Fellowship in Multiple Myeloma at the Dana-Farber Cancer Institute (DFCI) and Brigham and Women’s Hospital (BWH) is a 1-2 year fellowship program designed to provide comprehensive, clinical and investigative training in multiple myeloma for individuals who will ultimately pursue a career in clinically applied research in an academic setting.  The primary aim of the program is to prepare qualified individuals for careers that have a significant impact on the care and outcomes of patients undergoing treatment for multiple myeloma and on clinical research advances.

At the time of entry into the program, fellows must have already completed training in Medical Oncology (minimum 2 years), Hematology (minimum 2 years) or Hematology/Oncology (minimum 3 years) and be eligible for a limited or full medical license from the Commonwealth of Massachusetts.  

Applicants should submit a letter of interest/personal statement, CV, USMLE scores, and three letters of reference (one of which must be from current fellowship director) to:

Dr. Paul Richardson

Division of Hematologic Malignancies

Dana-Farber Cancer Institute

450 Brookline Ave, Boston MA 02215

attn: Ms. Katie Kupferberg

Administrative Director

Dana-Farber Cancer Institute is an NCI-designated Comprehensive Cancer Center. We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law.